Company registration number 16207613 (England and Wales)
PRIMARY CARE RESEARCH ALLIANCE LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED
31 MARCH 2026
PAGES FOR FILING WITH REGISTRAR
The Granary
Hones Yard
1 Waverley Lane
Farnham
Surrey
GU9 8BB
PRIMARY CARE RESEARCH ALLIANCE LIMITED
CONTENTS
Page
Company information
1
Balance sheet
2 - 3
Notes to the financial statements
4 - 9
PRIMARY CARE RESEARCH ALLIANCE LIMITED
COMPANY INFORMATION
- 1 -
Directors
Mr S. Gore
Dr D. Hazell
Company number
16207613
Registered office
Middleton House
Yapton Road
Middleton-on-Sea
West Sussex
PO22 6DU
Accountants
TC Group
The Granary
Hones Yard
1 Waverley Lane
Farnham
Surrey
GU9 8BB
PRIMARY CARE RESEARCH ALLIANCE LIMITED
BALANCE SHEET
AS AT
31 MARCH 2026
31 March 2026
- 2 -
2026
2025
Notes
£
£
£
£
Fixed assets
Tangible assets
4
704
-
0
Current assets
Debtors
5
28,799
-
0
Cash at bank and in hand
20,613
100
49,412
100
Creditors: amounts falling due within one year
6
(49,306)
-
0
Net current assets
106
100
Total assets less current liabilities
810
100
Provisions for liabilities
(134)
-
0
Net assets
676
100
Capital and reserves
Called up share capital
7
100
100
Profit and loss reserves
576
-
0
Total equity
676
100

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 March 2026 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

PRIMARY CARE RESEARCH ALLIANCE LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 MARCH 2026
31 March 2026
- 3 -
The financial statements were approved by the board of directors and authorised for issue on 3 August 2026 and are signed on its behalf by:
Mr S. Gore
Director
Company Registration No. 16207613
PRIMARY CARE RESEARCH ALLIANCE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026
- 4 -
1
Accounting policies
Company information

Primary Care Research Alliance Limited is a private company limited by shares incorporated in England and Wales. The registered office is Middleton House, Yapton Road, Middleton-on-Sea, West Sussex, PO22 6DU.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

1.2
Going concern

A true t the time of approving the financial statements, t he directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus t he directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Turnover

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that it is probable will be recover ed.

Revenue also includes introductory fees which are recognised at a point in time when it is contractually payable.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computers
25% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

PRIMARY CARE RESEARCH ALLIANCE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
1
Accounting policies
(Continued)
- 5 -
1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

1.6
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.7
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

PRIMARY CARE RESEARCH ALLIANCE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
1
Accounting policies
(Continued)
- 6 -
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.8
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.9
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

PRIMARY CARE RESEARCH ALLIANCE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
1
Accounting policies
(Continued)
- 7 -
1.10
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2026
2025
Number
Number
Total
2
2
3
Taxation
2026
2025
£
£
Current tax
UK corporation tax on profits for the current period
2
-
0
Deferred tax
Origination and reversal of timing differences
134
-
0
Total tax charge
136
-
0
PRIMARY CARE RESEARCH ALLIANCE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
- 8 -
4
Tangible fixed assets
Computers
£
Cost
At 1 April 2025
-
0
Additions
704
At 31 March 2026
704
Depreciation and impairment
At 1 April 2025 and 31 March 2026
-
0
Carrying amount
At 31 March 2026
704
At 31 March 2025
-
0
5
Debtors
2026
2025
Amounts falling due within one year:
£
£
Trade debtors
23,846
-
0
Other debtors
4,953
-
0
28,799
-
0
6
Creditors: amounts falling due within one year
2026
2025
£
£
Trade creditors
39,866
-
0
Corporation tax
2
-
0
Other creditors
9,438
-
0
49,306
-
0
PRIMARY CARE RESEARCH ALLIANCE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
- 9 -
7
Called up share capital
2026
2025
2026
2025
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary of £1 each
100
100
100
100
8
Related party transactions

The company entered into transactions with two compan ies that w ere under common control.

The company incurred expenses of £25,200 from one of those companies and was recharged expenses of £501 from the other company.

At the balance sheet date the company owed £25,200 to one of the compan ies under common control.

As a wholly owned subsidiary of Gazell Holdings Limited, the company has taken advantage of the exemption available under FRS 102 Section 33.1A not to disclose transactions with other wholly-owned members of the group.

2026-03-31 2025-04-01 false false true 03 August 2026 CCH Software CCH Accounts Production 2026.100 No description of principal activity Mr S. Gore Dr D. Hazell 16207613 2025-04-01 2026-03-31 16207613 bus:Director1 2025-04-01 2026-03-31 16207613 bus:Director2 2025-04-01 2026-03-31 16207613 bus:RegisteredOffice 2025-04-01 2026-03-31 16207613 2026-03-31 16207613 2025-03-31 16207613 core:ComputerEquipment 2026-03-31 16207613 core:ComputerEquipment 2025-03-31 16207613 core:CurrentFinancialInstruments core:WithinOneYear 2026-03-31 16207613 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 16207613 core:CurrentFinancialInstruments 2026-03-31 16207613 core:CurrentFinancialInstruments 2025-03-31 16207613 core:ShareCapital 2026-03-31 16207613 core:ShareCapital 2025-03-31 16207613 core:RetainedEarningsAccumulatedLosses 2026-03-31 16207613 core:RetainedEarningsAccumulatedLosses 2025-03-31 16207613 core:ShareCapitalOrdinaryShareClass1 2026-03-31 16207613 core:ShareCapitalOrdinaryShareClass1 2025-03-31 16207613 core:ComputerEquipment 2025-04-01 2026-03-31 16207613 2025-01-24 2025-03-31 16207613 core:UKTax 2025-04-01 2026-03-31 16207613 core:UKTax 2025-01-24 2025-03-31 16207613 core:ComputerEquipment 2025-03-31 16207613 bus:OrdinaryShareClass1 2025-04-01 2026-03-31 16207613 bus:OrdinaryShareClass1 2026-03-31 16207613 bus:OrdinaryShareClass1 2025-03-31 16207613 bus:EntityHasNeverTraded 2025-04-01 2026-03-31 16207613 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 16207613 bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 16207613 bus:FRS102 2025-04-01 2026-03-31 16207613 bus:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 16207613 bus:FullAccounts 2025-04-01 2026-03-31 xbrli:pure xbrli:shares iso4217:GBP